|
RNF138 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.695200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.679560E-02 |
| Normal-vs-Stage2 |
1.319170E-01 |
| Normal-vs-Stage3 |
7.862300E-02 |
| Normal-vs-Stage4 |
7.442400E-02 |
| Stage1-vs-Stage2 |
7.971400E-01 |
| Stage1-vs-Stage3 |
7.262200E-01 |
| Stage1-vs-Stage4 |
8.084200E-01 |
| Stage2-vs-Stage3 |
6.036400E-01 |
| Stage2-vs-Stage4 |
6.183600E-01 |
| Stage3-vs-Stage4 |
9.944600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.676000E-03 |
| Normal-vs-AfricanAmerican |
1.306980E-01 |
| Normal-vs-Asian |
5.239900E-03 |
| Caucasian-vs-AfricanAmerican |
4.944000E-01 |
| Caucasian-vs-Asian |
2.462400E-01 |
| AfricanAmerican-vs-Asian |
1.825420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.022000E-03 |
| Normal-vs-Female |
3.348200E-01 |
| Male-vs-Female |
6.153900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.059900E-02 |
| Normal-vs-Extreme_Weight |
2.108200E-02 |
| Normal-vs-Obese |
5.640000E-02 |
| Normal-vs-Extreme_Obese |
7.543700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.996600E-01 |
| Normal_Weight-vs-Obese |
6.954400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.246800E-01 |
| Extreme_Weight-vs-Obese |
6.701200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.301600E-01 |
| Obese-vs-Extreme_Obese |
7.288200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.510400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.714610E-01 |
| Normal-vs-Age(61-80Yrs) |
1.176560E-03 |
| Normal-vs-Age(81-100Yrs) |
1.947220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.550100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.231400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.334400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.168800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.439200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.210770E-01 |
| Normal-VS-Type2 PRCC |
5.83650000000047E-05 |
| Normal-VS-KIRP CIMP |
7.179600E-01 |
| Normal-VS-Unclassified PRCC |
2.531800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.843300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.919400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.913000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.945900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.488110E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.617000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.536720E-03 |
| Normal-vs-N1 |
1.901190E-01 |
| Normal-vs-N2 |
2.410100E-02 |
| N0-vs-N1 |
2.413400E-01 |
| N0-vs-N2 |
5.768400E-01 |
| N1-vs-N2 |
3.399600E-01 |
|
|
